Annals of internal medicine
-
Multicenter Study
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.
The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain. ⋯ Bayer Hispania.